Myoblast-mediated gene transfer for therapeutic angiogenesis (Q46733913)

24 December 2017

title

Myoblast-mediated gene transfer for therapeutic angiogenesis (English)

1 reference

24 December 2017

0 references

1

1 reference

24 December 2017

Helen Blau

series ordinal

3

object named as

Helen M Blau

1 reference

24 December 2017

author name string

Matthew L Springer

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

24 December 2017

published in

Methods in Enzymology

1 reference

24 December 2017

volume

346

1 reference

24 December 2017

page(s)

145-157

1 reference

24 December 2017

Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Blood vessel maturation: vascular development comes of age

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Angiogenesis in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

The well-tempered vessel

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Angiopoietin-1 protects the adult vasculature against plasma leakage.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

PR39, a peptide regulator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

VEGF gene delivery to muscle: potential role for vasculogenesis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Induction of angiogenesis by implantation of encapsulated primary myoblasts expressing vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Muscle-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

High-efficiency retroviral infection of primary myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Systemic delivery of recombinant proteins by genetically modified myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Cyclosporin A as a means of preventing rejection of skeletal muscle allografts in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Measurement of blood flow to the adrenal capsule, cortex and medulla in dogs after hemorrhage by fluorescent microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Measurement of regional myocardial blood flow with multiple colored microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

Angiogenesis monitored by perfusion with a space-filling microbead suspension

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2802%2946054-5

7 January 2021

10.1016/S0076-6879(02)46054-5

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017